Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 3 minute read Pharma Industry News Kyowa Kirin secures extended EC approval for CRYSVITA in X-linked hypophosphataemia treatment Kyowa Kirin has recently received expanded approval from the European Commission (EC) for its recombinant monoclonal antibody treatment,… bypharmanewsdailyOctober 4, 2020
